Undisclosed Muscular Dystrophy Program(s)

About miRecule

miRecule is an emerging biotechnology company focused on the discovery and development of precision RNA therapeutics for oncology and neuromuscular disorders. Its core strategy involves analyzing patient genomic data to inform the design of targeted RNA-based drugs, aiming to address unmet medical needs with a personalized medicine approach. As a newly founded, private company, it is in the pre-clinical or early research stage, positioning itself in the competitive but high-potential fields of RNA and gene therapy. The company's success will hinge on validating its platform and advancing its initial pipeline candidates.

Therapeutic Areas

Other Muscular Dystrophy Drugs